These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5682239)

  • 21. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
    Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
    Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood.
    Eng PA; Borer-Reinhold M; Heijnen IA; Gnehm HP
    Allergy; 2006 Feb; 61(2):198-201. PubMed ID: 16409196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care.
    Röder E; Berger MY; Hop WC; Bernsen RM; de Groot H; Gerth van Wijk R
    J Allergy Clin Immunol; 2007 Apr; 119(4):892-8. PubMed ID: 17321581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive symptomatic immunotherapy versus placebo in seasonal rhinitis due to grasses in children and to Parietaria in adult patients.
    Troise C; Bignardi D; Modena P; Pissacroia C; Di Berardino F
    Allerg Immunol (Paris); 2000 Jun; 32(6):246-9. PubMed ID: 10971859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Endonasal allergoid therapy of seasonal allergic rhinosinusitis].
    Giusan AO
    Vestn Otorinolaringol; 1985; (6):81-2. PubMed ID: 4090168
    [No Abstract]   [Full Text] [Related]  

  • 27. The significance of testing and hyposensitization with several grass pollens for hay fever.
    Heijer A; Göransson K
    Acta Allergol; 1968 May; 23(2):146-60. PubMed ID: 5755560
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study.
    Giovannini M; Braccioni F; Sella G; Contoli M; Perri G; Frati F; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):69-71. PubMed ID: 15859367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A modified therapy of hayfever with a depot-preparation (author's transl)].
    Skoda-Türk R; Horak F; Jäger S
    Wien Klin Wochenschr Suppl; 1980; 117():24-6. PubMed ID: 6936978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ragweed treatment problems.
    Guiang SF
    Ann Allergy; 1970 Jan; 28(1):31-2. PubMed ID: 5526411
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunological and clinical studies on the pollen-L-tyrosin complexes in hyposensitization therapy].
    Horak F
    Wien Med Wochenschr; 1977 Nov; 127(22):677-81. PubMed ID: 595610
    [No Abstract]   [Full Text] [Related]  

  • 32. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of hay fever with an aluminum--precipitated pyridine grass pollen extract ("Allpyral grass mix")].
    Bruun E
    Ugeskr Laeger; 1967 Jun; 129(26):874-6. PubMed ID: 5599499
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hay fever with new pollen capsules].
    Stickl H; Kerscher G
    Fortschr Med; 1980 Mar; 98(10):343-6. PubMed ID: 7372223
    [No Abstract]   [Full Text] [Related]  

  • 36. Leukocyte histamine release and humoral changes during oral and subcutaneous hyposensitization of grass pollen allergic children.
    Wahn U; Maasch HJ; Geissler W
    Helv Paediatr Acta; 1984 May; 39(2):137-44. PubMed ID: 6085730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grass and ragweed pollinosis therapy. Seventeen-year study (1955 to 1971).
    Sobel G
    N Y State J Med; 1972 Aug; 72(16):2048-57. PubMed ID: 4505329
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical studies of a purified timothy pollen extract. Desensitization therapy with a purified timothy pollen preparation compared to a crude timothy pollen extract. I. Results of tests in vivo.
    Berg T; Nordvall SL; Lanner A
    Int Arch Allergy Appl Immunol; 1980; 63(3):266-74. PubMed ID: 7419290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
    Kleine-Tebbe J; Ribel M; Herold DA
    Allergy; 2006 Feb; 61(2):181-4. PubMed ID: 16409193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis.
    Senna GE; Andri G; Dama AR; Falagiani P; Andri L
    Allergol Immunopathol (Madr); 2000; 28(4):238-42. PubMed ID: 11022271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.